|
1
|
Zhu RX, Seto WK, Lai CL and Yuen MF:
Epidemiology of hepatocellular carcinoma in the Asia-Pacific
region. Gut Liver. 10:332–339. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hiotis SP, Rahbari NN, Villanueva GA,
Klegar E, Luan W, Wang Q and Yee HT: Hepatitis B vs. hepatitis C
infection on viral hepatitis-associated hepatocellular carcinoma.
BMC Gastroenterol. 12:642012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu LM, Xiong DD, Lin P, Yang H, Dang YW
and Chen G: DNA topoisomerase 1 and 2A function as oncogenes in
liver cancer and may be direct targets of nitidine chloride. Int J
Oncol. 53:1897–1912. 2018.PubMed/NCBI
|
|
4
|
Faillaci F, Marzi L, Critelli R, Milosa F,
Schepis F, Turola E, Andreani S, Vandelli G, Bernabucci V, Lei B,
et al: Liver Angiopoietin-2 is a key predictor of de novo or
recurrent hepatocellular cancer after hepatitis C virus direct
acting antivirals. Hepatology. 68:1010–1024. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jin R, Lin H, Li G, Xu J, Shi L, Chang C
and Cai X: TR4 nuclear receptor suppresses HCC cell
invasion via downregulating the EphA2 expression. Cell Death Dis.
9:2832018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Daveau M, Scotte M, François A, Coulouarn
C, Ros G, Tallet Y, Hiron M, Hellot MF and Salier JP: Hepatocyte
growth factor, transforming growth factor alpha, and their
receptors as combined markers of prognosis in hepatocellular
carcinoma. Mol Carcinog. 36:130–141. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song PP, Xia JF, Inagaki Y, Hasegawa K,
Sakamoto Y, Kokudo N and Tang W: Controversies regarding and
perspectives on clinical utility of biomarkers in hepatocellular
carcinoma. World J Gastroenterol. 22:262–274. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schulze K, Imbeaud S, Letouzé E,
Alexandrov LB, Calderaro J, Rebouissou S, Couchy G, Meiller C,
Shinde J, Soysouvanh F, et al: Exome sequencing of hepatocellular
carcinomas identifies new mutational signatures and potential
therapeutic targets. Nat Genet. 47:505–511. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sekhar V, Pollicino T, Diaz G, Engle RE,
Alayli F, Melis M, Kabat J, Tice A, Pomerenke A, Altan-Bonnet N, et
al: Infection with hepatitis C virus depends on TACSTD2, a
regulator of claudin-1 and occludin highly downregulated in
hepatocellular carcinoma. PLoS Pathog. 14:e10069162018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Diaz G, Engle RE, Tice A, Melis M,
Montenegro S, Rodriguez-Canales J, Hanson J, Emmert-Buck MR, Bock
KW, Moore IN, et al: Molecular signature and mechanisms of
hepatitis D virus-associated hepatocellular carcinoma. Mol Cancer
Res. 16:1406–1419. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wurmbach E, Chen YB, Khitrov G, Zhang W,
Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, et
al: Genome-wide molecular profiles of HCV-induced dysplasia and
hepatocellular carcinoma. Hepatology. 45:938–947. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mas VR, Maluf DG, Archer KJ, Yanek K, Kong
X, Kulik L, Freise CE, Olthoff KM, Ghobrial RM, McIver P and Fisher
R: Genes involved in viral carcinogenesis and tumor initiation in
hepatitis C virus-induced hepatocellular carcinoma. Mol Med.
15:85–94. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saito I, Miyamura T, Ohbayashi A, Harada
H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, et al:
Hepatitis C virus infection is associated with the development of
hepatocellular carcinoma. Proc Natl Acad Sci USA. 87:6547–6599.
1999. View Article : Google Scholar
|
|
16
|
McGivern DR and Lemon SM: Virus-specific
mechanisms of carcinogenesis in hepatitis C virus associated liver
cancer. Oncogene. 30:1969–1983. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lupberge J, Croonenborghs T, Roca Suarez
AA, Van Renne N, Jühling F, Oudot MA, Virzì A, Bandiera S, Jamey C,
Meszaros G, et al: Combined analysis of metabolomes, proteomes and
transcriptomes of HCV-infected cells and liver to identify pathways
associated with disease development. Gastroenterology.
pii:S0016-S5085(19)35670-7. 2019.
|
|
18
|
Wu SY, Lan SH and Liu HS: Degradative
autophagy selectively regulates CCND1 (cyclin D1) and MIR224, two
oncogenic factors involved in hepatocellular carcinoma
tumorigenesis. Autophagy. 15:729–730. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sartor H, Ehlert F, Grzeschik KH, Müller R
and Adolph S: Assignment of two human cell cycle genes, CDC25C and
CCNB1, to 5q31 and 5q12, respectively. Genomics. 13:911–912. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matthess Y, Raab M, Sanhaji M, Lavrik IN
and Strebhardt K: Cdk1/cyclin B1 controls Fas-mediated apoptosis by
regulating caspase-8 activity. Mol Cell Biol. 30:5726–5740. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song Y, Zhao C, Dong L, Fu M, Xue L, Huang
Z, Tong T, Zhou Z, Chen A, Yang Z, et al: Overexpression of cyclin
B1 in human esophageal squamous cell carcinoma cells induces tumor
cell invasive growth and metastasis. Carcinogenesis. 29:307–315.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Agarwal R, Gonzalez-Angulo AM, Myhre S,
Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A,
Neve RM, et al: Integrative analysis of cyclin protein levels
identifies cyclin b1 as a classifier and predictor of outcomes in
breast cancer. Clin Cancer Res. 15:3654–3662. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li JQ, Kubo A, Wu F, Usuki H, Fujita J,
Bandoh S, Masaki T, Saoo K, Takeuchi H, Kobayashi S, et al: Cyclin
B1, unlike cyclin G1, increases significantly during colorectal
carcinogenesis and during later metastasis to lymph nodes. Int J
Oncol. 22:1101–1110. 2003.PubMed/NCBI
|
|
24
|
Dong Y, Sui L, Watanabe Y, Sugimoto K and
Tokuda M: Clinical relevance of cyclin B1 overexpression in
laryngeal squamous cell carcinoma. Cancer Lett. 177:13–19. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weng L, Du J, Zhou Q, Cheng B, Li J, Zhang
D and Ling C: Identification of cyclin B1 and Sec62 as biomarkers
for recurrence in patients with HBV-related hepatocellular
carcinoma after surgical resection. Mol Cancer. 11:392012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li L, Lei Q, Zhang S, Kong L and Qin B:
Screening and identification of key biomarkers in hepatocellular
carcinoma: Evidence from bioinformatic analysis. Oncol Rep.
38:2607–2618. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miki H, Setou M, Kaneshiro K and Hirokawa
N: All kinesin superfamily protein, KIF, genes in mouse and human.
Proc Natl Acad Sci USA. 98:7004–7011. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kawai Y, Shibata K, Sakata J, Suzuki S,
Utsumi F, Niimi K, Sekiya R, Senga T, Kikkawa F and Kajiyama H:
KIF20A expression as a prognostic indicator and its possible
involvement in the proliferation of ovarian clear-cell carcinoma
cells. Oncol Rep. 40:195–205. 2018.PubMed/NCBI
|
|
29
|
Taniuchi K, Furihata M and Saibara T:
KIF20A-mediated RNA granule transport system promotes the
invasiveness of pancreatic cancer cells. Neoplasia. 16:1082–1093.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu SL, Lin HX, Qiu F, Zhang WJ, Niu CH,
Wen W, Sun XQ, Ye LP, Wu XQ, Lin CY, et al: Overexpression of
kinesin family member 20A correlates with disease progression and
poor prognosis in human nasopharyngeal cancer: A retrospective
analysis of 105 patients. PLoS One. 12:e01692802017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi C, Huang D, Lu N, Chen D, Zhang M, Yan
Y, Deng L, Lu Q, Lu H and Luo S: Aberrantly activated Gli2-KIF20A
axis is crucial for growth of hepatocellular carcinoma and predicts
poor prognosis. Oncotarget. 7:26206–26219. 2016.PubMed/NCBI
|
|
32
|
Fagerberg L, Hallström BM, Oksvold P,
Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S,
Danielsson A, Edlund K, et al: Analysis of the human
tissue-specific expression by genome-wide integration of
transcriptomics and antibody-based proteomics. Mol Cell Proteomics.
13:397–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maxwell CA, McCarthy J and Turley E:
Cell-surface and mitotic-spindle RHAMM: Moonlighting or dual
oncogenic functions? J Cell Sci. 121:925–932. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Telmer PG, Tolg C, McCarthy JB and Turley
EA: How does a protein with dual mitotic spindle and extracellular
matrix receptor functions affect tumor susceptibility and
progression? Commun Integr Biol. 4:182–185. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Turley EA, Noble PW and Bourguignon LY:
Signaling properties of hyaluronan receptors. J Biol Chem.
277:4589–4592. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tilghman J, Wu H, Sang Y, Shi X,
Guerrero-Cazares H, Quinones-Hinojosa A, Eberhart CG, Laterra J and
Ying M: HMMR maintains the stemness and tumorigenicity of
glioblastoma stem-like cells. Cancer Res. 74:3168–3179. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang C, Thor AD, Moore DH II, Zhao Y,
Kerschmann R, Stern R, Watson PH and Turley EA: The overexpression
of RHAMM, a hyaluronan-binding protein that regulates ras
signaling, correlates with overexpression of mitogen-activated
protein kinase and is a significant parameter in breast cancer
progression. Clin Cancer Res. 4:567–576. 1998.PubMed/NCBI
|
|
38
|
He X, Liao W, Li Y, Wang Y, Chen Q, Jin J
and He S: Upregulation of hyaluronan-mediated motility receptor in
hepatocellular carcinoma predicts poor survival. Oncol Lett.
10:3639–3646. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ferenci P, Fried M, Labrecque D, Bruix J,
Sherman M, Omata M, Heathcote J, Piratsivuth T, Kew M, Otegbayo JA,
et al: World gastroenterology organisation guideline.
Hepatocellular carcinoma (HCC): A global perspective. J
Gastrointestin Liver Dis. 19:311–317. 2010.PubMed/NCBI
|
|
40
|
Gurtsevitch VE: Human oncogenic viruses:
Hepatitis B and hepatitis C viruses and their role in
hepatocarcinogenesis. Biochemistry (Mosc). 73:504–513. 2008.
View Article : Google Scholar : PubMed/NCBI
|
